Ytterbium Yb-169

Ytterbium-169 (Yb-169) is a radioactive isotope of ytterbium that emits low-energy gamma radiation, making it useful mainly in medical applications, especially in brachytherapy, a type of internal radiation therapy. Due to its relatively low photon energy (93 keV average) and short half-life of approximately 32 days, Yb-169 is particularly suited for treating small, localized tumors including prostate or eye cancers, where precise dose delivery with minimal damage to surrounding healthy tissues is critical. Its radiation properties allow for excellent imaging contrast and therapeutic effectiveness, while also offering advantages in radiation safety due to limited tissue penetration. Additionally, Yb-169 has been explored in industrial radiography for the inspection of thin materials and small components where high-resolution imaging is required without the need for high-energy sources. It is grouped under the following drug class(es): Radiopharmaceuticals. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Yb-169 radioisotope, Ytterbium and isotope of mass 169. Its PubChem CID is 105164.

CAS No 14269-78-4
Molecular Formula Yb
Molecular Weight 168.94 g/mol
Synonyms ytterbium-169

Frequently Asked Questions